Cargando…

The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases

PURPOSE: The aim of this study is to evaluate the clinical utility of automated breast volume scanner (ABVS) for detecting and diagnosing the breast lesions. METHODS: From December 2010 to January 2012, bilateral whole breast examinations were performed with ABVS for 139 women. Based on the Breast I...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Wook, Kim, Seon Kwang, Youn, Hyun Jo, Choi, Eun Jung, Jung, Sung Hoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800730/
https://www.ncbi.nlm.nih.gov/pubmed/24155763
http://dx.doi.org/10.4048/jbc.2013.16.3.329
_version_ 1782288021121400832
author Kim, Young Wook
Kim, Seon Kwang
Youn, Hyun Jo
Choi, Eun Jung
Jung, Sung Hoo
author_facet Kim, Young Wook
Kim, Seon Kwang
Youn, Hyun Jo
Choi, Eun Jung
Jung, Sung Hoo
author_sort Kim, Young Wook
collection PubMed
description PURPOSE: The aim of this study is to evaluate the clinical utility of automated breast volume scanner (ABVS) for detecting and diagnosing the breast lesions. METHODS: From December 2010 to January 2012, bilateral whole breast examinations were performed with ABVS for 139 women. Based on the Breast Imaging Reporting and Data System (BI-RADS) categories, the breast lesions were evaluated on coronal multiplanar reconstruction images using the ABVS workstation. Then, the imaging results were compared with those on conventional handheld ultrasound (HHUS) images. Histological diagnoses were performed on BI-RADS category 4 and 5 lesions. RESULTS: A total of 453 lesions were detected by ABVS. On the HHUS, 33 new lesions were detected but 69 lesions were not detected. BI-RADS category 2 and 3 matched to those on ABVS at 73.5% (61/83) and 85.4% (276/323). In 47 lesions of BI-RADS category 4 or 5, there was an exact match to those on ABVS. In addition, 47 lesions were classified as BI-RADS category 4 and 5, for which an ultrasound-guided core needle biopsy was performed. The malignant lesions of BI-RADS category 4 and 5 showed the following: 2/27 (7.4%) in 4A, 4/5 (80%) in 4B, 2/2 (100%) in 4C, and 13/13 (100%) in 5. The ABVS showed 21 true positives and a positive predictive value of 44.7% (21/47). CONCLUSION: There was considerable agreement in the assessment of the breast lesions by ABVS and HHUS. The ABVS had advantages of high diagnostic accuracy, examiner-independence, multislice visualization of the whole breast and less time-consuming. Our results indicate that ABVS might be a useful modality in diagnosing breast lesions.
format Online
Article
Text
id pubmed-3800730
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Korean Breast Cancer Society
record_format MEDLINE/PubMed
spelling pubmed-38007302013-10-23 The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases Kim, Young Wook Kim, Seon Kwang Youn, Hyun Jo Choi, Eun Jung Jung, Sung Hoo J Breast Cancer Original Article PURPOSE: The aim of this study is to evaluate the clinical utility of automated breast volume scanner (ABVS) for detecting and diagnosing the breast lesions. METHODS: From December 2010 to January 2012, bilateral whole breast examinations were performed with ABVS for 139 women. Based on the Breast Imaging Reporting and Data System (BI-RADS) categories, the breast lesions were evaluated on coronal multiplanar reconstruction images using the ABVS workstation. Then, the imaging results were compared with those on conventional handheld ultrasound (HHUS) images. Histological diagnoses were performed on BI-RADS category 4 and 5 lesions. RESULTS: A total of 453 lesions were detected by ABVS. On the HHUS, 33 new lesions were detected but 69 lesions were not detected. BI-RADS category 2 and 3 matched to those on ABVS at 73.5% (61/83) and 85.4% (276/323). In 47 lesions of BI-RADS category 4 or 5, there was an exact match to those on ABVS. In addition, 47 lesions were classified as BI-RADS category 4 and 5, for which an ultrasound-guided core needle biopsy was performed. The malignant lesions of BI-RADS category 4 and 5 showed the following: 2/27 (7.4%) in 4A, 4/5 (80%) in 4B, 2/2 (100%) in 4C, and 13/13 (100%) in 5. The ABVS showed 21 true positives and a positive predictive value of 44.7% (21/47). CONCLUSION: There was considerable agreement in the assessment of the breast lesions by ABVS and HHUS. The ABVS had advantages of high diagnostic accuracy, examiner-independence, multislice visualization of the whole breast and less time-consuming. Our results indicate that ABVS might be a useful modality in diagnosing breast lesions. Korean Breast Cancer Society 2013-09 2013-09-30 /pmc/articles/PMC3800730/ /pubmed/24155763 http://dx.doi.org/10.4048/jbc.2013.16.3.329 Text en © 2013 Korean Breast Cancer Society. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Young Wook
Kim, Seon Kwang
Youn, Hyun Jo
Choi, Eun Jung
Jung, Sung Hoo
The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases
title The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases
title_full The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases
title_fullStr The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases
title_full_unstemmed The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases
title_short The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases
title_sort clinical utility of automated breast volume scanner: a pilot study of 139 cases
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800730/
https://www.ncbi.nlm.nih.gov/pubmed/24155763
http://dx.doi.org/10.4048/jbc.2013.16.3.329
work_keys_str_mv AT kimyoungwook theclinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT kimseonkwang theclinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT younhyunjo theclinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT choieunjung theclinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT jungsunghoo theclinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT kimyoungwook clinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT kimseonkwang clinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT younhyunjo clinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT choieunjung clinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases
AT jungsunghoo clinicalutilityofautomatedbreastvolumescannerapilotstudyof139cases